Don’t Call It Project Orbis: CoGenT Global Will Pilot Collaborative Review Of Gene Therapies

Although still in the early stages of development, the US FDA's Collaboration on Gene Therapies Global Pilot will explore the potential for concurrent submission and collaborative review of applications with international regulatory partners.

Levers
Pooling global forces to review gene therapies is 'another lever that we have to pull,' FDA's Peter Marks said. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies